These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4007403)

  • 21. Lichenoid drug eruption from chlorpropamide and tolazamide.
    Franz CB; Massullo RE; Welton WA
    J Am Acad Dermatol; 1990 Jan; 22(1):128-9. PubMed ID: 2137135
    [No Abstract]   [Full Text] [Related]  

  • 22. Profound hypoglycemia with the addition of a tricyclic antidepressant to maintenance sulfonylurea therapy.
    True BL; Perry PJ; Burns EA
    Am J Psychiatry; 1987 Sep; 144(9):1220-1. PubMed ID: 3631324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use and abuse of oral hypoglycemic agents.
    Sussman KE
    Rocky Mt Med J; 1967 Feb; 64(2):56-9. PubMed ID: 6045352
    [No Abstract]   [Full Text] [Related]  

  • 24. Chlorpropamide-induced water retention in patients with diabetes mellitus.
    Garcia M; Miller M; Moses AM
    Ann Intern Med; 1971 Oct; 75(4):549-54. PubMed ID: 5094069
    [No Abstract]   [Full Text] [Related]  

  • 25. [Study of oral hypoglycemic agents. VI. Comparative study on acute oral overload using tolbutamide and tolazamide in normal and diabetic subjects. Various aspects of the prolonged use of tolazamide in comparison with other sulfonylureas].
    Pereira VG; Wajchenberg BL; Shnaider J
    Arq Bras Endocrinol Metabol; 1965 Aug; 14(2):133-42. PubMed ID: 5322747
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of sulphonylureas (tolazamide, tolbutamide and chlorpropamide) on the metabolism of diphenylhydantoin in the rat.
    Wesseling H; Thurkow I; Mulder G
    Biochem Pharmacol; 1973 Dec; 22(23):3033-40. PubMed ID: 4761563
    [No Abstract]   [Full Text] [Related]  

  • 27. CLINICAL STUDIES OF TOLAZAMIDE AND TOLBUTAMIDE: COMPARATIVE EFFECTIVENESS OF CONTROL OF DIABETES MELLITUS.
    RENNIE CS; ANDERSON DO
    Can Med Assoc J; 1963 Sep; 89(13):669-71. PubMed ID: 14077815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hypoglycemia caused by oral antidiabetic agents].
    de Baere H; Decraene P; de Leeuw I; Lemmens P; Verhaegen H
    Ned Tijdschr Geneeskd; 1973 Jul; 117(27):1021-4. PubMed ID: 4206176
    [No Abstract]   [Full Text] [Related]  

  • 29. A new oral hypoglycemic agent. Tolazamide (Tolinase).
    JAMA; 1966 Oct; 198(3):308-9. PubMed ID: 5952933
    [No Abstract]   [Full Text] [Related]  

  • 30. METABOLISM OF ANTIDIABETIC SULFONYLUREAS IN MAN. I. BIOLOGICAL HALF-LIVES OF THE P-ACETYLBENZENESULFONYLUREAS, U-18536 AND ACETOHEXAMIDE AND THEIR METABOLITES.
    SMITH DL; VECCHIO TJ; FORIST AA
    Metabolism; 1965 Mar; 14():229-40. PubMed ID: 14261407
    [No Abstract]   [Full Text] [Related]  

  • 31. Oral hypoglycemic therapy and associated hypothyroidism.
    Schless GL; Lee CT
    Ann N Y Acad Sci; 1968 Mar; 148(3):813-9. PubMed ID: 4172964
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of chronic oral antidiabetic therapy on insulin and glucagon responses to a meal.
    Tsalikian E; Dunphy TW; Bohannon NV; Lorenzi M; Gerich JE; Forsham PH; Kane JP; Karam JH
    Diabetes; 1977 Apr; 26(4):314-21. PubMed ID: 849812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [ACTION OF HYPOGLYCEMIC SULFONAMIDES ON THE PRODUCTION OF CO2 BY ADIPOSE TISSUE OF THE RAT EPIDIDYMIS "IN VITRO"].
    MARQUES M; RIETCORREA P
    Folia Endocrinol; 1964 Jun; 17():381-6. PubMed ID: 14210726
    [No Abstract]   [Full Text] [Related]  

  • 34. [Chlorpropamide and other oral hypoglycemic agents in the treatment of diabetes mellitus resistant to tolbutamide. Clinico-statistical study].
    Danelon-Martina L
    Clin Ter; 1969 Apr; 49(2):135-46. PubMed ID: 5407314
    [No Abstract]   [Full Text] [Related]  

  • 35. Tolazamide in the treatment of diabetes mellitus.
    Baird IM; Evans JH; Hirst J; Longson D
    Practitioner; 1967 Feb; 198(184):264-7. PubMed ID: 6038982
    [No Abstract]   [Full Text] [Related]  

  • 36. [CONTRIBUTION TO THE STUDY OF THE TOXIC EFFECTS DUE TO HYPOGLYCEMIC SULFONYLUREAS].
    CIAMMAICHELLA A; CANTERA N
    Minerva Med; 1964 Mar; 55():657-64. PubMed ID: 14140236
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypoglycemic coma, jaundice, and pure RBC aplasia following chlorpropamide therapy.
    Gill MJ; Ratliff DA; Harding LK
    Arch Intern Med; 1980 May; 140(5):714-5. PubMed ID: 7396601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of tolazamide "'Tolanase') as an oral hypoglycaemic agent.
    Tewari SN; Fletcher R
    Br J Clin Pract; 1967 Sep; 21(9):455-6. PubMed ID: 4864489
    [No Abstract]   [Full Text] [Related]  

  • 39. The pharmacology of sulfonylureas.
    Skillman TG; Feldman JM
    Am J Med; 1981 Feb; 70(2):361-72. PubMed ID: 6781341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Editorial: Oral therapy in diabetes mellitus.
    Scoville AB
    South Med J; 1974 Jun; 67(6):635-8. PubMed ID: 4208385
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.